AMDL Inc. Announces Stockholder Approval of Name Change and Issuance of a New Trading Symbol on the NYSE Al... (Company anticipates market launch and co...)

AMDL Inc. Announces Stockholder Approval of Name Change and Issuance of a New Trading Symbol on the NYSE Alternext US

Date:9/18/2009

Company anticipates market launch and commercialization of the introductory Elleuxe(TM) product line targeted to women in the luxury market in late Q1FY10 to early Q2FY10. In FY10, the Company plans to launch two additional product lines. In total there will be eight separate product formulations for Elleuxe(TM).

Elleuxe(TM) will be sold directly to high-end retail stores, high-end beauty spas and medical day spas. The Company anticipates it will sell the product sets (grouped based on skin types) at between $500 and $650 and the individual products in the set at $100-$350 per ounce.

The Global Luxury Skin Care Market is growing at a 7-8% CAGR and is expected to reach $22.1B by FY2013.

For additional information on AMDL and AMDL Diagnostics Inc. please contact AMDL Investor Relations at kszarkowitz@amdl.com or by calling 206.310.5323.

About AMDL:

Headquartered in Tustin, CA with operations in China, AMDL, Inc., along with its subsidiary Jade Pharmaceutical Inc. (JPI), is a pharmaceutical company devoted to the research, development, manufacturing, and marketing of diagnostic, pharmaceutical, nutritional supplement, and cosmetic products. The Company employs over 510 people in the U.S. and China.

Forward Looking Statements:

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained in this document include certain predictions and projections that may be considered forward-looking statements under securities law. These statements involve a number of important risks and uncertainties that could cause actual results to differ materially includ
'/>"/>

SOURCE AMDL Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5
Related biology technology :

1. LCA-Vision Announces CEO Resignation
2. Regado Biosciences Announces Allowance in Europe of a Fundamental Patent Broadly Covering Oligonucleotide Modulators to Blood Coagulation Factor Aptamers
3. Rigel Announces Pricing of Public Offering of 13,000,000 Shares of Common Stock
4. InterMune Announces Collaboration With National Jewish Health on NIH-Supported Genetic Research in Idiopathic Pulmonary Fibrosis
5. Aethlon Medical, Inc. Announces Annual Meeting Results
6. Sangamo BioSciences Announces Presentation at the UBS Global Life Sciences Conference
7. Martek Announces Addition to Its Board of Directors
8. Pervasis Therapeutics Announces $17 Million in Financing and New Board Member
9. BVGH Announces New Board Chair
10. Poniard Pharmaceuticals Announces Pivotal Phase 3 SPEAR Trial Evaluating Picoplatin in Small Cell Lung Cancer Reaches 320th Event Target
11. Enerkem Announces Construction Start on Advanced Energy Research Facility in Edmonton, Alberta

Post Your Comments:

(Date:12/16/2009)... Technological University (NTU) signed the Memorandum of Understanding ... Research (CNRS) and the Thales Group of Companies ... three parties are meeting again in Singapore to ... NTU. , Located at the Research Techno ... latest in science and technology to develop innovations ...

(Date:12/16/2009)... -- Cord Blood America, Inc. (OTC Bulletin Board: ... company ( http://www.cordblood-america.com ) focused on bringing ... biological insurance policy, to families nationwide and internationally, ... by a total of $1.4 million so far ... debt eliminated for the year now tops $10 ...

(Date:12/16/2009)... Assessment with the Food and Drug Administration ... AEterna Zentaris Inc. (NASDAQ: AEZS ; ... company focused on oncology and endocrine therapy, ... Keryx Biopharmaceuticals Inc. ("Keryx") ( KERX), of ... perifosine (KRX-0401), the Company,s PI3K/Akt pathway inhibitor, ...

(Date:12/15/2009)... SAN MARINO, Calif., Dec. 15 Epeius ... of targeted genetic medicine, gained international validation of ... Rexin-G , when scientists around the world ... be a major locus of cancer pathogenesis and ... anti-cancer therapies. Recently, scientists at the NIH National ...

Breaking Biology Technology:New Singapore-French nanotech lab opens at NTU 2 New Singapore-French nanotech lab opens at NTU 3 Cord Blood America Says 2009 Debt Reduction Tops $10 Million 2 Cord Blood America Says 2009 Debt Reduction Tops $10 Million 3 AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 2 AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 3 AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 4 AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 5 Scientists Rediscover Gene Target for Cancer Therapy 2 Scientists Rediscover Gene Target for Cancer Therapy 3

[0] New Singapore-French nanotech lab opens at NTU [0] Cord Blood America Says 2009 Debt Reduction Tops $10 Million [0] AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma [0] Scientists Rediscover Gene Target for Cancer Therapy

... 2004 is rapidly coming to a close, the fourth quarter represents ... eight states. Witness the more important of these events: , , ... a lot of biotech activities! This is a good sign and ... 2006 annual meeting in Chicago. Its also an indicator that biotech ...

... identified, search engines are leading the way for consumers ... related to the efficacy of these search engines, among ... soon and why could this happen? , ,If search ... todays search results, which often include a great deal ...

... barrel spring, are old enough not to be patented ... past decade, the economy has been experiencing an accelerated shift ... patent for a novel medical device, an internet-based business method ... design in the pharmaceutical industry can form the basis for ...

Other Biology Technology:Furious pace of Midwest biotech events marks progress 2 Furious pace of Midwest biotech events marks progress 3 When search engines collide 2 When search engines collide 3 When search engines collide 4 Patent essentials for business owners: from patent to profit 2 Patent essentials for business owners: from patent to profit 3 Patent essentials for business owners: from patent to profit 4 Patent essentials for business owners: from patent to profit 5

Furious pace of Midwest biotech events marks progress When search engines collide Patent essentials for business owners: from patent to profit

(Date:12/16/2009)... Scotland, Canada and the US have proposed a ... conservation. The team,s findings, published in Animal ... identified through feeding behaviour, can benefit highly mobile ... are enormous challenges associated with setting conservation priorities ... said lead author Erin Ashe, a PhD student ...

(Date:12/16/2009)... out of every drop of water is a high priority for ... and dry and vines have to be irrigated to make it ... significant portion of the water applied to the vines zips right ... about 10 percent of the water that is applied is lost ... the soil and vine roots," said Eve Hinckley, who worked on ...

(Date:12/16/2009)... exposure to pesticides in rivers and basins may ... populations. In addition to the widespread deterioration of ... commonly used pesticides may further inhibit the recovery ... efforts are currently underway to restore Pacific salmon ... says David Baldwin of the National Oceanic and ...

[0] Zoning the ocean may help endangered whales to recover [0] Lost water of the Napa Valley vineyards [0] Even at sublethal levels, pesticides may slow the recovery of wild salmon populations

... or stroke, paramedics, doctors, and nurses follow standardized protocols for ... odds for a full recovery. That's not the case if ... be fatal within a few hours and is often not ... new, multicenter research consortium, called Protocolized Care for Early Septic ...

... known to be important for the survival of many ... neurons ?critical brain cells that connect the cerebral cortex ... neuron diseases like amyotrophic lateral sclerosis (ALS or Lou ... Nature Neuroscience, two investigators from Massachusetts General Hospital (MGH) ...

... regarding DNA: How can parts of such a rigid ... force? According to a team of researchers from ... physicist from the University of Pennsylvania, DNA is much ... small lengths. They used a technique called atomic ...

Other Biology News:New study aims to stop sepsis in its tracks 2 New study aims to stop sepsis in its tracks 3 Growth factor stimulates rapid extension of key motor neurons in brain 2 Penn researcher shows that DNA gets kinky easily at the nanoscale 2

New study aims to stop sepsis in its tracks Growth factor stimulates rapid extension of key motor neurons in brain Penn researcher shows that DNA gets kinky easily at the nanoscale

Edited by D.M. Gersten (1996) Provides comprehensive descriptions of the techniques available for analytical gel electrophoresis of proteins and offers clear step-by-step protocols for all of the m...

... Edited by John M. Walker ... highly successful analytical techniques for studying ... tested protocol contains detailed, step-by-step instruction, ... explanations and comprehensive lists of reagents ...

...

ANTI S. ENT TOX BC2D...

Biology Products:

Essential Techniques: Gel Electrophoresis: Proteins from Promega The Protein Protocols Handbook from Promega Human Leptin Receptor, soluble (Ob sR) ELISA Kit from R&D Systems Mouse Anti-STAPHYLOCOCCUS ENTEROTOXIN B (+C2, +D) Monoclonal Antibody, Unconjugated, Clone S5 from AbD Serotec

AMDL Inc. Announces Stockholder Approval of Name Change and Issuance of a New Trading Symbol on the NYSE Al...(Company anticipates market launch and co...)